Philips IntelliSpace Cognition is a digital cognitive assessment tool that helps neurologists gain insight into their patients' cognition, empowering them to make more appropriate referral and treatment decisions.
It’s easy to get started and take your in-office assessments to the next level.
It is easy to use and supports a streamlined workflow. Assessments are scored immediately and stored in the cloud for later review. This is all tremendously valuable.”
Dr. Nandor Pinter, Dent Neurologic Institute, NY
It’s like having a perfect assistant in the room. The battery of tests allows for a very good balance of insights about cognitive functions.”
Dr. Yvette Feis, Neuropsychologist, NY
The assessment consists of a battery of cognitive tests. Minimal supervision is needed, and practices can deploy any healthcare provider, including medical assistants, to supervise.
Powerful cloud-based software analyzes the inputs, scores the tests, and compares them against healthy norms. Then the proprietary algorithms analyze results and instantaneously map them onto cognitive domains.
Longitudinal tracking is included in reports at both the individual test level and as cognitive domains. Reports can be exported and appended to the EHR.
Computerized cognitive testing has become even more relevant in the current environment of increased infection risk. See how IntelliSpace Cognition can be utilized along with social distancing and telehealth.
Getting started with Intellispace Cognition is easy and quick. The clinician portal is web-based, so all you need is an iPad Pro and an Apple Pencil for patient testing.
Choose the plan that is right for your practice. There are no startup fees and no commitment.
Philips IntelliSpace Cognition:
Scientific validation of a new digital cognitive assessment tool
Current customers can log into their IntelliSpace Cognition dashboard below.
1. Based on normative data collected from healthy US-based volunteers (N=300) ages 50 to 80, 2019.
2. MarkeTech Group, Davis, CA. Study of 75 neurologists with clinical practices, commissioned by Philips 2018.
3. Ranson and Langa, Predictors of dementia misclassification when using brief cognitive assessments, Neurology practice month 2010 volume 9 no. 1-19
4. Based on a 2019 Philips study with 100 neurologists.
5. Based on a 2020 Philips study with 90 neurologists.
Data is collected by means of an easy-to-administer digital assessment, supervised by an assistant and completed in 45 minutes. Advanced data analytics are then used to automatically score the tests and map these scores to cognitive domains. This gives you an instant overview of current performance, as well as a comparison with historical data.
It can be challenging to generate accurate insight into a patient’s cognition in the time available. The initial screening process is often insufficient to aid in diagnosis or treatment, while results from individual cognitive tests can be difficult for staff to interpret.1 Philips IntelliSpace Cognition uses a scientific model2,3 that first norms the raw test scores and then translates these into easy-to-digest results, organized by widely recognized cognitive domains.
It is essential to systematically track patients’ cognitive status throughout the course of their treatment path, such as assessing how they respond to medication or other measures. Doing so also helps you explain changes in cognitive performance to the patient and family. With Philips IntelliSpace Cognition, you have access to longitudinal reporting of performance in each of the main cognitive domains. Automated scoring algorithms generate easily comparable scores, time after time.
